Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Epidermal growth factor receptor [695-1022,T790M,C797S,L858R] | ||
Ligand | BDBM525490 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | Biochemical EGFR Inhibition Assays (5 mM ATP) | ||
IC50 | 1.90±n/a nM | ||
Citation | Boese, D; Dahmann, G; Engelhardt, H; Petronczki, M; Scharn, D Benzimidazole compounds and derivatives as EGFR inhibitors US Patent US11174245 Publication Date 11/16/2021 | ||
More Info.: | Get all data from this article, Assay Method | ||
Epidermal growth factor receptor [695-1022,T790M,C797S,L858R] | |||
Name: | Epidermal growth factor receptor [695-1022,T790M,C797S,L858R] | ||
Synonyms: | EGFR | EGFR (aa 695-1022, L858R, T790M, C797S) | EGFR_HUMAN | ERBB | ERBB1 | HER1 | ||
Type: | Enzyme Catalytic Domain | ||
Mol. Mass.: | 37397.86 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P00533[695-1022,T790M,C797S,L858R] | ||
Residue: | 328 | ||
Sequence: |
| ||
BDBM525490 | |||
n/a | |||
Name | BDBM525490 | ||
Synonyms: | US11174245, # I-143 | ||
Type | Small organic molecule | ||
Emp. Form. | C24H26N6O2 | ||
Mol. Mass. | 430.5022 | ||
SMILES | Cc1cc(cc(n1)-c1cnn(C)c1)C(=O)\N=c1/[nH]c2ccccc2n1[C@@H]1CC[C@H](O)CC1 |r,wU:25.28,28.32,(4.98,5.6,;4.21,4.26,;2.67,4.26,;1.9,2.93,;2.67,1.6,;4.21,1.6,;4.98,2.93,;4.98,.26,;6.52,.26,;6.99,-1.2,;5.75,-2.11,;5.75,-3.65,;4.5,-1.2,;.36,2.93,;-.41,4.26,;-.41,1.6,;-1.95,1.6,;-2.86,2.84,;-4.32,2.37,;-5.66,3.14,;-6.99,2.37,;-6.99,.83,;-5.66,.06,;-4.32,.83,;-2.86,.35,;-2.46,-1.14,;-3.55,-2.22,;-3.15,-3.71,;-1.66,-4.11,;-1.27,-5.6,;-.57,-3.02,;-.97,-1.53,)| | ||
Structure |